Overall survival in patients with glioblastoma before and after bevacizumab approval
Overall survival in patients with glioblastoma before and after bevacizumab approval is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall survival in patients with glioblastoma before and after bevacizumab approval have?
Overall survival in patients with glioblastoma before and after bevacizumab approval has 42 citations in the OpenAlex counts ScholarIQ stores.
When was Overall survival in patients with glioblastoma before and after bevacizumab approval published?
Overall survival in patients with glioblastoma before and after bevacizumab approval has 2017 year in the ScholarIQ index.
What is the open-access status of Overall survival in patients with glioblastoma before and after bevacizumab approval?
Overall survival in patients with glioblastoma before and after bevacizumab approval has closed oa status in the ScholarIQ index.
What is the DOI of Overall survival in patients with glioblastoma before and after bevacizumab approval?
The DOI for Overall survival in patients with glioblastoma before and after bevacizumab approval is on the source record.
What is the PMID of Overall survival in patients with glioblastoma before and after bevacizumab approval?
The PMID for Overall survival in patients with glioblastoma before and after bevacizumab approval is on the source record.
What is the OpenAlex record for Overall survival in patients with glioblastoma before and after bevacizumab approval?
The OpenAlex for Overall survival in patients with glioblastoma before and after bevacizumab approval is on the source record.